Session Information
2009 BIO International Convention
Click here to go to the previous page
Life Cycle of a Life Sciences Company: Best Practices from Fundraising through the Exit
Track : Finance
Program Code: 3290
Date: Monday, May 18, 2009
Time: 4:00 PM to 5:30 PM  EST
Location: B314
SPEAKER (S):
James Datin, Safeguard Scientifics, Inc
Howie Furst, Partner, Deerfield Partners
David King, Quaker BioVentures
Gwen Melincoff, Shire Pharmaceuticals, Inc
Steven Nichtberger, MD, Tengion, Inc
Philip Ross, JP Morgan Securities
Description
Over the past ten years, the venture capital marketplace has changed dramatically. As the economy attempts to right itself, VCs are increasing their scrutiny and due diligence to fi nd viable, growing companies to invest in—which means fundraising itself will continue to evolve. Today, the savviest of companies excel in all areas of the life cycle—from the initial business plan, through fundraising efforts, and eventually, successful exits. By securing financing and valuable partnerships early on, a company positions itself to continue to grow and develop its business model, and, eventually, secure a lucrative exit that benefits all parties involved.

• Analyze life cycle of a life sciences company—including initial concept, business plan development, fundraising and ultimately positioning for a successful exit
• Highlight fundraising best practices and discuss pitfalls entrepreneurs and investors should avoid
• Explore how entrepreneurs and investors can best position companies for successful, well-timed exits


Audio Synchronized to PowerPoint
(Code: 3290)
  
This session is a part of: